DR ROBERT BOLDERMAN
ActiveSummary
DR ROBERT BOLDERMAN has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €650k and a net result of €296k. Equity is growing by ~34.5% per year across the filed fiscal years. Its solvency ranks better than 91% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
98
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 20.13 against 36.29 in 2024; short-term debt: 4.9% and cash: 58.8% of total assets), and 5.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
94.7%
Return on assets
43.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-07-2026, 27 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
27 d early
2024
10 d early
2023
13 d early
2022
19 d early
2021
34 d early
2020
31 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€650k▼ 37.1%
2024 · €1.03M
2020: €89k
2021: €275k
2022: €595k
2023: €732k
2024: €1.03M
2020 → 2025
Total assets
€686k▼ 35.5%
2024 · €1.06M
2020: €176k
2021: €400k
2022: €672k
2023: €820k
2024: €1.06M
2020 → 2025
Net result
€296k▼ 1.5%
2024 · €301k
2020: €84k
2021: €185k
2022: €320k
2023: €282k
2024: €301k
2020 → 2025
Working capital
€640k▼ 36.9%
2024 · €1.01M
2020: €17k
2021: €220k
2022: €532k
2023: €697k
2024: €1.01M
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€275k-€595k▲ 117%€732k▲ 23.1%€1.03M▲ 41.1%€650k▼ 37.1%
Operating result€244k-€423k▲ 73.6%€370k▼ 12.6%€396k▲ 7.1%€389k▼ 1.7%
Net result€185k-€320k▲ 72.8%€282k▼ 12.1%€301k▲ 6.9%€296k▼ 1.5%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 2% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €686k
Fixed assets
€12k ▼ 41.5%
Current assets
€674k ▼ 35.4%
Equity and liabilities €686k
Equity
€650k ▼ 37.1%
Debt
€36k ▲ 18.5%
Debt's share of the balance-sheet total rises from 2.9% to 5.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€404k▼
2024 · €412k
Cash flow
€311k▼
2024 · €317k
Current ratio
20.13▼
2024 · 36.29
Debt to equity
0.06▲
2024 · 0.03
ROE
45.6%▲
2024 · 29.1%
ROA
43.2%▲
2024 · 28.3%
Interest coverage
2784.11▼
2024 · 5600.08
Debt ≤ 1 year
€33k▲
2024 · €29k
Income taxes
€93k▼
2024 · €95k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.06M€686k▼
Fixed assets21/28€21k€12k▼
Tangible fixed assets22/27€21k€12k▼
Furniture and vehicles24€12k€4k▼
Other tangible fixed assets26€9k€8k▼
Financial fixed assets28€200€200=
Current assets29/58€1.04M€674k▼
Amounts receivable within one year40/41€314k€268k▼
Trade receivables40€285k€236k▼
Other amounts receivable41€29k€31k▲
Cash at bank and in hand54/58€726k€403k▼
Deferred charges and accrued income490/1€3k€3k▲
Equity and liabilities
Total equity and liabilities10/49€1.06M€686k▼
Equity10/15€1.03M€650k▼
Contributions10/11€5k€5k=
Reserves13€1.03M€645k▼
Distributable reserves133€1.03M€645k▼
Amounts payable17/49€31k€36k▲
Amounts payable within one year42/48€29k€33k▲
Trade debts44€985-
Suppliers440/4€985-
Taxes, remuneration and social security45€8k€5k▼
Taxes450/3€8k€5k▼
Other amounts payable47/48€20k€29k▲
Accrued charges and deferred income492/3€2k€3k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16k€15k▼
Other operating charges640/8€126€128▲
Gross operating margin9900€412k€404k▼
Operating profit (loss)9901€396k€389k▼
Financial charges65/66B€74€145▲
Recurring financial charges65€74€145▲
Profit (loss) for the period before taxes9903€396k€389k▼
Income taxes67/77€95k€93k▼
Profit (loss) for the period9904€301k€296k▼
Profit (loss) for the period to be appropriated9905€301k€296k▼
Appropriation of the result
Profit (loss) to be appropriated9906€301k€296k▼
Transfer from equity791/2-€680k
Transfer to equity691/2€301k€296k▼
To other reserves6921€301k€296k▼
Profit to be distributed694/7-€680k
Return on contributions (dividend)694-€680k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
21-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity quadruplescurrent ratio 36.29
Current ratio from 9.06 to 36.29; short-term debt falls from €86k to €29k.
31-12
Financial
Equity above €1MEq €1.03M ▲41.1%
5 profitable years in a row build equity to €1.03M.
18-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
12-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Highest result since 2020net €320k ▲72.8%
Operating result €423k, net result €320k, both a record.
31-12
Financial
Liquidity triplescurrent ratio 8.00
Current ratio from 2.80 to 8.00; short-term debt falls from €123k to €76k.
31-12
Financial
Equity above €500kEq €595k ▲117%
3 profitable years in a row build equity to €595k.
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Liquidity doublescurrent ratio 2.80
Current ratio from 1.19 to 2.80.
31-12
Financial
Equity above €200kEq €275k ▲208%
2 profitable years in a row build equity to €275k.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Harelbeke · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Bistierland 28530 HarelbekeGround area
13.7 ha
Building footprint
3.5 ha
2 parcels, Flanders. Linked by address, not a title deed.
1 establishment unit
Dr. Robert Bolderman
since 20202.298.050.061
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34026A0631/00H000 | Flanders | 13.7 ha | 1 · 3.4 ha | - |
| 34323D1437/00M005 | Flanders | 655 m² | 1 · 125 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
98450086CBFAFB852E22
Similar companies · same sector, comparable size
Dr. Jan De Vlieger
BE 0725.813.188
Waasmunster · Eq €649,402
Dr. Isabelle Debergh, abdominaal chirurg
BE 0757.603.553
Gent · Eq €649,934
Dr.Koen De Feyter
BE 0865.769.837
Nijlen · Eq €649,122
CABINET MEDICAL DU DR LIBOIS
BE 0474.719.087
Thuin · Eq €648,869
Société Médicale du Docteur Kurth Isabelle
BE 0822.840.607
Nandrin · Eq €650,916
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,220 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-01-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.